1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Mycosis Fungoides Global Clinical Trials Review, H1, 2014

Mycosis Fungoides Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H1, 2014" provides data on the Mycosis Fungoides clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mycosis Fungoides. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mycosis Fungoides. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Mycosis Fungoides Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Mycosis Fungoides 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mycosis Fungoides to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mycosis Fungoides to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mycosis Fungoides 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Mycosis Fungoides Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Takeda Pharmaceutical Company Limited 35
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 35
Shionogi and Co., Ltd. 36
Clinical Trial Overview of Shionogi and Co., Ltd. 36
Kirin Holdings Company, Limited 37
Clinical Trial Overview of Kirin Holdings Company, Limited 37
Eisai Co., Ltd. 38
Clinical Trial Overview of Eisai Co., Ltd. 38
Actelion Ltd 39
Clinical Trial Overview of Actelion Ltd 39
Janssen Global Services, LLC 40
Clinical Trial Overview of Janssen Global Services, LLC 40
Emergent BioSolutions Inc. 41
Clinical Trial Overview of Emergent BioSolutions Inc. 41
Echo Therapeutics, Inc. 42
Clinical Trial Overview of Echo Therapeutics, Inc. 42
Angimmune LLC 43
Clinical Trial Overview of Angimmune LLC 43
Clinical Trial Overview of Top Institutes / Government 44
National Cancer Institute 44
Clinical Trial Overview of National Cancer Institute 44
Fred Hutchinson Cancer Research Center 46
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 46
Northwestern University 48
Clinical Trial Overview of Northwestern University 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
Stanford University 50
Clinical Trial Overview of Stanford University 50
The University of Texas M. D. Anderson Cancer Center 51
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
Case Comprehensive Cancer Center 53
Clinical Trial Overview of Case Comprehensive Cancer Center 53
Barbara Ann Karmanos Cancer Institute 54
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 54
Wake Forest University 55
Clinical Trial Overview of Wake Forest University 55
Five Key Clinical Profiles 56
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 100

List of Tables
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mycosis Fungoides Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mycosis Fungoides Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Mycosis Fungoides Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mycosis Fungoides Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mycosis Fungoides Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Mycosis Fungoides Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Mycosis Fungoides to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mycosis Fungoides to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mycosis Fungoides Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mycosis Fungoides Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Mycosis Fungoides Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Mycosis Fungoides Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Mycosis Fungoides Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Mycosis Fungoides Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Mycosis Fungoides Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Mycosis Fungoides Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Mycosis Fungoides Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 34
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 35
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi and Co., Ltd., 2014* 36
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 37
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 38
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 39
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 40
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 41
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Echo Therapeutics, Inc., 2014* 42
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Angimmune LLC, 2014* 43
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 44
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 46
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 48
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 49
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 50
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 51
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 52
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 53
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 54
Mycosis Fungoides Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 55

List of Figures
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mycosis Fungoides Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mycosis Fungoides Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Mycosis Fungoides Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mycosis Fungoides Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mycosis Fungoides Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Mycosis Fungoides Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Mycosis Fungoides to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mycosis Fungoides Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mycosis Fungoides to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mycosis Fungoides Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mycosis Fungoides Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mycosis Fungoides Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mycosis Fungoides Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mycosis Fungoides Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Mycosis Fungoides Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Mycosis Fungoides Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Mycosis Fungoides Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Mycosis Fungoides Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016 - 2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of ...

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025

  • $ 4995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.